Search

CareDx Inc

Open

SectorHealthcare

49.61 0.59

Overview

Share price change

24h

Current

Min

48.29

Max

50.12

Key metrics

By Trading Economics

Income

108M

111M

Sales

14M

132M

P/E

Sector Avg

24.091

56.659

EPS

0.17

Profit margin

83.848

Employees

761

EBITDA

-3.8M

4.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+3.23% upside

Dividends

By Acuity

Next Earnings

3 lis 2026

Market Stats

By TradingEconomics

Market Cap

714M

2.6B

Previous open

49.02

Previous close

49.61

News Sentiment

By Acuity

100%

0%

326 / 340 Ranking in Healthcare

CareDx Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2026, 20:08 UTC

News

Canaccord Genuity initiated coverage on CareDx with a Buy rating and a $65 price target, contributing to the stock's upward movement during the session.

1 wrz 2026, 20:09 UTC

CareDx Inc shares are lower amid a broader market downturn. Investors are responding to macroeconomic concerns, including rising oil prices and inflation worries.

31 sie 2026, 20:07 UTC

CareDx Inc shares are higher, recovering from an early dip amid broader market volatility and macroeconomic concerns regarding inflation and interest rates.

28 sie 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

27 sie 2026, 19:51 UTC

Shares of CareDx Inc. are advancing amid unusually high trading volume. Earlier in the session, shares pulled back from a session high.

26 sie 2026, 20:08 UTC

CareDx Inc shares are higher today, regaining momentum after earlier pulling back. The broader market reflects mixed performance amid recent inflation data.

25 sie 2026, 20:07 UTC

CareDx Inc. shares are higher today, reflecting a strong upward move since Monday amid easing Treasury yields that support equities and investor sentiment.

24 sie 2026, 19:26 UTC

Social Media

CareDx Inc shares are lower today, despite social media discussions projecting a price target of $75 by 2027 and expected revenues of $575 million.

21 sie 2026, 23:01 UTC

CareDx Inc shares are higher in after-market trading, reflecting notable activity despite broader market volatility and no specific company news identified.

20 sie 2026, 20:06 UTC

CareDx Inc. shares are higher, recovering from an earlier pullback, amid rising crude oil prices and increased U.S. Treasury yields influencing market dynamics.

19 sie 2026, 23:56 UTC

CareDx Inc shares are higher in after-market hours, remaining above their 20-day moving average. No specific news was identified to explain the movement.

18 sie 2026, 20:04 UTC

CareDx Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. The stock remains down since Monday's close.

14 sie 2026, 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

12 sie 2026, 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

11 sie 2026, 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

10 sie 2026, 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

7 sie 2026, 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

5 sie 2026, 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

4 sie 2026, 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

3 sie 2026, 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

31 lip 2026, 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

30 lip 2026, 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

29 lip 2026, 19:56 UTC

CareDx Inc shares are lower, continuing a six-session decline amid rising crude oil prices and inflation concerns affecting broader market sentiment.

27 lip 2026, 19:16 UTC

News

CareDx Inc is trading lower today, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

22 lip 2026, 19:16 UTC

CareDx Inc shares are lower today with no specific news identified. Broader market sentiment is affected by rising crude oil prices amid geopolitical tensions.

20 lip 2026, 18:53 UTC

News

CareDx shares are lower as Director Valantine Hannah sold 28,779 shares at prices between $36.14 and $36.55, raising investor concerns.

Peer Comparison

Price change

CareDx Inc Forecast

Price Target

By TipRanks

3.23% upside

12 Months Forecast

Average 51.2 USD  3.23%

High 65 USD

Low 21 USD

Based on 6 Wall Street analysts offering 12 month price targets forCareDx Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

3

Buy

3

Hold

0

Sell

Sentiment

By Acuity

326 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat